03.02.2016 - Shares of Merck continues to decline

Merck on Wednesday reported a net profit of 976 million US dollars for the 4th quarter, against 7.3 billion dollars for the same period in 2014. Sales fell to 10.2 billion dollars against 10.5 billion a year earlier. Given the strong deterioration of financial results, we expect a continuation of the negative dynamics of stock price, but in the second half of the year, the picture may change, and we will review our forecast.

Merck Symbol

RISK WARNING: Trading of complex financial products, such as Stocks, Futures, Foreign Exchange ("Forex"), Contracts for Difference ("CFDs"), Indices, Options, or other financial derivatives, on "margin" carries a high level of risk, and may not be suitable for all investors. The possibility exists that you could sustain a loss of some or all of your initial investment and, therefore, you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading these markets, and seek advice from an independent financial advisor if you have any questions or doubts. Please carefully read our full "Risk Disclosure" and "Risk Disclosures for Financial Instruments & Investment Services". FXFINPRO Capital is the trading name of PFX Financial Professionals Limited, a limited liability company formed under the laws of Cyprus, registered with the Registrar of Companies in Nicosia, Cyprus, under nr. HE 237840 and regulated by the Cyprus Securities and Exchange Commission with license number 193/13.